TransDigm beat expectations with strong Q3 sales growth and margin expansion driven by its value-driven strategy, while also authorizing share repurch...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
TOP Financial Group announced a strategic expansion to launch a dedicated Artificial Intelligence division, integrating advanced AI solutions to optim...
Barnwell Industries intends to acquire artificial intelligence venture Truth Terminal via a $1.77 million agreement with that venture's creator. This ...
Xometry's Q2 2026 revenue surged 41% to a record $229 million. The marketplace sector grew by 45% year-over-year, driving further adjusted EBITDA impr...
Shoals Technologies Group reported record second quarter revenue and backlog; profitability was impacted by facilities transition and product quality ...
Allens provided legal counsel to IREN for the filing of an SEC registration statement covering the resale of ordinary shares. The document confirms th...
Superior Group reported Q2 2026 net sales of $147.8 million, up 2.6% year-over-year. The board declared a quarterly dividend of $0.14 per share and co...
Camp4 amended its securities purchase agreement to allow the reallocation of unrequested securities ahead of the second closing. This extends the wait...
Certara reported second quarter revenue growth of 1%, a change from net income to a net loss for the period. The company reaffirmed 2026 revenue guida...
AdaptHealth reported second-quarter financial results, highlighting organic growth, portfolio concentration around core health areas, and a strategic ...
Beam Therapeutics dosed the first patient in the global pivotal cohort of its BEAM-302 trial for AATD and reported $1.2 billion in cash, indicating co...
Enpro reported a strong second quarter with 17.6% sales growth driven by semiconductor demand, raising full-year 2026 revenue guidance to 14-16% while...
iBio, Inc. has entered into an Employment Agreement with Molly Carr, who will serve as Chief Medical Officer and report to the CEO. The effective date...
Elite Pharmaceuticals announced the U.S. commercial launch of its generic Requip XL tablets, a non-ergoline dopamine agonist used to treat Parkinson's...
RYTHM, Inc. reported second quarter 2026 revenue jumping 73% sequentially to $23.0 million and achieving net income of $1.2 million, a positive shift ...
Katapult Holdings, Inc. reported positive Q2 financial results driven by organic growth and a significant reduction in net losses, alongside the annou...
Wayfair reported $3.5 billion in net revenue for Q2 2026, driven by a 7.5% year-over-year increase and a net loss of just $1 million, alongside strong...
Larimar Therapeutics submitted the first module of a rolling BLA for nomlabofusp in June and reported $156.3 million in cash as of June 30, 2026, exte...
Pfizer achieved operational revenue growth in Q2 2026 and raised its full-year 2026 revenue guidance, demonstrating continued business strength despit...
USA Compression reported a 36.8% increase in revenue to $342.1 million for Q2 2026, driven by operational integration and the utilization of new horse...